Back

Non-HDL cholesterol and residual risk of myocardial infarction and death in statin-treated patients with and without diabetes

25 August 2023 (10:15 - 10:50)
Organised by: Logo
Congress Presentation Part of: Cardiovascular risk assessment (1) Cardiovascular Risk Assessment ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Malene Kaerslund Hansen

Regionshospitalet Randers, Aarhus (Denmark)

5 More presentations in this session

Presentation thumbnail
Inferior vena cava wall thickness is associated with the presence and severity of cardiovascular disease.
Doctor K. Fujiyoshi (Kanagawa, JP)
Abstract Slides Video
Presentation thumbnail
Typical and atypical chest pain: an equivocal and dangerous definition
Doctor D. Cosmi (Perugia, IT)
Abstract Slides Video
Presentation thumbnail
Prevalence of subclinical coronary artery atherosclerosis in the general population- apollo subclinical coronary atherosclerosis project (ASCAP)
Doctor L. Narra (Hyderabad, IN)
Abstract Slides Video
Presentation thumbnail
Influence of Lp(a) and systemic inflammation on all-cause mortality in a primary prevention population: data from our clinic database
Doctor L. Cho (Cleveland, US)
Abstract Slides Video
Presentation thumbnail
Carotid plaque score for stroke and cardiovascular risk prediction in a middle-aged cohort from the general population: the akershus cardiac examination 1950 study
Mr H. Ihle-Hansen (Gjettum, NO)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular risk assessment (1)

The Event

Event poster

ESC Congress 2023

25 August 2023 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Composition of non-HDL cholesterol and residual cardiovascular risk in secondary prevention
thumbnail
Congress Presentation
Elevated remnant cholesterol in atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study
thumbnail
Congress Presentation
Exploring residual cardiovascular risk beyond LDL cholesterol in patients with acute destabilisation of known significant atherosclerosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources